Home

Alliance Development

BIO’s Mission is to be the champion for biotechnology. We advocate for policies that will enable the realization of biotechnology’s promise for providing breakthrough products to cure disease, protecting against bio-terrorism, feeding the hungry, and cleaning our environment.

Kimball Thomson, President & CEO at BioUtah

Kimball Thomson, President & CEO of BioUtah discusses his organization and what makes Utah a good place for innovative industry growth.

Building Biotech Hubs; Biomanufacturing Attractors and Accelerators

Bioscience economic development in a nation as large and diverse as the United States is as varied as the country itself.  A complex array of factors influence the allocation of resources and the nature of bioscience industry development.

Tracey Mumford from The Michael J. Fox Foundation for Parkinson’s Research

Tracey Mumford from The Michael J. Fox Foundation discusses Parkinson's disease, the Foundation’s work toward a cure, and partnerships they're currently seeking. The Foundation will be one of the patient advocacy groups attending the 2012 BIO International Convention on June 18-21 in Boston, Mass.  

Preventing Heart Disease: Lisa Tate, CEO of WomenHeart

Lisa Tate, CEO of WomenHeart, the National Coalition for Women with Heart Disease, discusses what we can each do to prevent heart disease.

Successful State Initiatives That Encourage Bioscience Industry Growth

State governments in 2011 continued to see regional economic growth in the life sciences industry and in 2012 will increasingly focus attention on technology transfer and venture funding as mechanisms to increase private sector innovation related activities within their jurisdictions. Realizing that entrepreneurship is a key ingredient in economic development, states and localities are undertaking the support of programs that assist high technology businesses, and that capitalize on state regional presence of universities and federal laboratories.

Podcast with Aaron Miscenich

Aaron Miscenich, president of the New Orleans BioInnovation Center and chairman of LouisianaBio, discusses the bioscience economic development initiatives.

New Orleans Biotech Center Drives Job Growth and Diversifies Economy

New Orleans shows the signs of a city reborn from the destruction brought on by Hurricane Katrina.  The changes in the city’s infrastructure and building projects have certainly been among them.  The city reached a  milestone its renaissance when the New Orleans BioInnovation Center (NOBIC) opened for business.

BIO China: Eastern Biotech Meets Western Biotech

With more than one-fifth of the world’s population, China is an important market for biotech products and is increasingly a key global player in biotech research, development and manufacturing.

BIO Grassroots Handbook

A strong Network will bolster public awareness of the industry and encourage more investment dollars.

Dr. Augustus White on the Diversity Summit in Washington, DC

Dr. Augustus White is a pioneer in equitable care. He will be delivering the keynote address at this year’s Diversity Summit at the 2011 BIO International Convention.

Worldview: A Global Biotechnology Perspective

Scientific American will release the third annual Worldview: A Global Biotechnology Perspective at this year's BIO International Convention.

Industrial Biotech Industry Leaders Discuss Keys To Strategic Partnership Success

The keys to successful industrial biotech business relationships mirror those for successful personal relationships, industry leaders explained today.  During the final Lunch Plenary Session of BIO’s 2011 World Congress in Toronto, moderator James Stoppert, CEO of BioAdvisors, along with panelists Patrick Gruber, CEO of Gevo, Ron Commander, Head of Butyl Rubber Business Unit at Lanxess, Christophe Schilling, CEO of Genomatica, and Hisao Urata, General Manager of Corporate Planning at Mitsubishi Chemical discussed “Strategic Partnerships for More Robust Value Chains” and identified some key components to that end.

BIO Business Forum Partnering: Building Value through Partnerships

Partnering decisions can make or break a company’s value. Pursuing the right partnership deal can ultimately increase a company’s value but conversely, the wrong decision can ultimately kill a company’ value.

BIO Poised to Partner with Chinese Leaders to Grow Biotech

This month, BIO is leading a delegation of biopharma CEOs to China for meetings with members of the Chinese biotech community and government leaders. The mission illustrates a strong commitment on behalf of the western biotechnology industry to encourage China to strengthen its support for biotech innovation and take steps to enhance greater investment and collaboration with companies in China. The series of meetings between China’s local industry and government leaders and biotech CEOs will lay the foundation for increased cooperation to help biotech flourish in China.

Changing Dynamic: Synthetic Biology Comes of Age

BIO review of this emerging science illustrates progress in applying synthetic biology to improve manufacturing processes.

Letters, Testimony & Comments

Letter Supporting Florida House Bill 365; Pertaining to requirements for pharmacist to dispense substitute biological product
February 1 2013
Representative Matt Hudson Florida House of Representatives 402 South Monroe Street Tallahassee, FL 32399 Dear Representative Hudson...
BIO Principles on Patient Safety in the Substitution of Biologic Products
January 24 2013
Biologics are complex medicines manufactured from living organisms. Unlike traditional “small molecule” drugs, biologics are...
Statement in Support Of North Dakota S.B. 2190
January 24 2013
The Biotechnology Industry Organization (BIO) is the world’s largest biotechnology trade association. BIO represents more than 1,...
Statement in Opposition to North Dakota S. 2066
January 24 2013
The Biotechnology Industry Organization (BIO) is the world’s largest biotechnology trade association. BIO represents more than 1,...
Statement in Support of Virginia H.B. 1422
January 10 2013
In December 2012, Virginia House Delegate John M. O'Bannon, III introduced the Interchangeable biosimilar biological products bill (H...
More Letters, Testimony & Comments →

Press Releases

Innovation and The Supreme Court: Two Cases to Watch
February 11 2013
  WHAT: An inside look at two cases facing the Supreme Court of the United States: Bowman v....
New Jersey Governor Chris Christie Presented 2012 BIO Governor of the Year Award
June 14 2012
WASHINGTON, DC (June 12, 2012) – The Biotechnology Industry Organization (BIO) announced today that New Jersey...
BIO Announces Expansion of Alliance Development Activities
March 2 2012
WASHINGTON, D.C. (March 2, 2012) – The Biotechnology Industry Organization (BIO) announced today that it has...
TREAT Act Offers Renewed Hope for Patients
February 15 2012
Washington, DC (February 15, 2012) – Today, the Biotechnology Industry Organization (BIO) praised Sen. Kay...
BIO Announces Fritz Bittenbender as the New Vice President, Alliance Development and State Government Relations
January 17 2012
The Biotechnology Industry Organization (BIO) announced today that Fritz Bittenbender has been hired to serve as Vice...
More Press Releases →